A number of studies have demonstrated that in vitro treatment of mesenchymal stem cells with epidermal growth factor, HBEGF, AREG or TGFα induces growth factor production 28, 29, 14 that may also affect malignant phenotypes such as cancer cell proliferation and metastasis 30, 31. This evidence concerns the gene HBEGF and cancer.